Page 34 - HTX Kompendium
P. 34
Literatur
• Van Matre ET, Satyanarayana G, Page 2nd RL, Levi ME, Lindenfeld J,
Mueller SW� Pharmacokinetic Drug-Drug Interactions Between
Immunosuppressant and Anti-Infective Agents: Antimetabolites
and Corticosteroids� Ann Transplant 2018;23:66-74�
• Kovarik JM, Eisen H, Dorent et al� Everolimus in de novo
cardiac transplantation: pharmacokinetics, therapeutic
range, and influence on Ciclosporine exposure� J Heart
Lung Transplant 2003; 22:1117-1125�
• Kovarik JM, Curtis JJ, Hricik DE, et al� Differential
pharmacokinetic interaction of tacrolimus and Ciclosporine
on everolimus� Transplant Proc� 2006; 38: 3456-3458�
• Warrington JS, Shaw LM� Pharmacogenetic differences and
drug-drug interactions in immunosuppressive therapy�
Expert Opin Drug Metab Toxicol 2005;1:487-503�
• Masuda S, Inui K� An up-to date review on individualized
dosage adjustment of calcineurin inhibitors in organ
transplant patients� Pharmacol Ther 2006; 184-198�
• Staatz CE, Tett SE� Clinical pharmacokinetics and
pharmacodynamics of tacrolimus in solid organ transplantation�
Clin Pharmacokinetics 2004;43: 624-645�
32 Austrotransplant